skip to main content

    Updated Visitor Guidelines

 

MENU

 

New Liquid Biopsy Improves Diagnosis of High-Grade Gliomas

Researchers are optimistic that cerebrospinal fluid could be a valuable source for tumor DNA that could help monitor and treat pediatric cancer patients with aggressive brain tumors known as high-grade gliomas.

Clinical Trial of Axitinab Successful for Patients with Head and Neck Cancer

When first- and second-line treatments have been exhausted, few options remain for patients with advanced head and neck cancer.

A new phase 2 clinical trial by researchers at the University of Michigan Rogel Cancer Center found the drug axitinib was able to extend the lives of these patients by several months, and also identified a subset of patients with a specific mutation for whom the drug is likely to work best.

Referencing Support Grant and Shared Resources

Whenever publishing about research supported by the Cancer Center Support Grant and/or our Shared Resources, please use the following:

Referencing the Cancer Center Support Grant

Research reported in this publication was supported by the National Cancer Institute under Award Number P30 CA046592. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Pages